Literature DB >> 24073680

Enterococcus faecalis infective endocarditis: focus on clinical aspects.

Anders Dahl1, Niels Eske Bruun.   

Abstract

Enterococcus faecalis infective endocarditis (IE) is a disease of increasing importance, with more patients infected, increasing frequency of health-care associated infections and increasing incidence of antimicrobial resistances. The typical clinical presentation is a subacute course with fever, malaise and generalized aches, difficult to distinguish from other more common diseases. Of paramount importance is transthoracic- and transesophageal-echocardiography to establish the diagnosis. At the moment, the predominant strategies recommend ampicillin in combination with either gentamicin or ceftriaxone. E. faecalis infective endocarditis continues to be a very serious disease with considerable percentages of high-level gentamicin resistant strains and in-hospital mortality around 20%. Strategies to prevent E. faecalis IE, improve diagnostics, optimize treatment and reduce morbidity will be necessary to improve the overall prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24073680     DOI: 10.1586/14779072.2013.832482

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  17 in total

1.  Targeting Enterococcus faecalis biofilms with phage therapy.

Authors:  Leron Khalifa; Yair Brosh; Daniel Gelman; Shunit Coppenhagen-Glazer; Shaul Beyth; Ronit Poradosu-Cohen; Yok-Ai Que; Nurit Beyth; Ronen Hazan
Journal:  Appl Environ Microbiol       Date:  2015-02-06       Impact factor: 4.792

Review 2.  When being alone is enough: noncanonical functions of canonical bacterial quorum-sensing systems.

Authors:  Bobbi Xayarath; Nancy E Freitag
Journal:  Future Microbiol       Date:  2016-10-18       Impact factor: 3.165

3.  Relevance of the clustered regularly interspaced short palindromic repeats of Enterococcus faecalis strains isolated from retreatment root canals on periapical lesions, resistance to irrigants and biofilms.

Authors:  Zhongchun Tong; Yu Du; Junqi Ling; Lijia Huang; Jinglei Ma
Journal:  Exp Ther Med       Date:  2017-09-27       Impact factor: 2.447

4.  Quantitative Proteomics of Strong and Weak Biofilm Formers of Enterococcus faecalis Reveals Novel Regulators of Biofilm Formation.

Authors:  Tanujaa Suriyanarayanan; Lin Qingsong; Lim Teck Kwang; Lee Yew Mun; Thuyen Truong; Chaminda Jayampath Seneviratne
Journal:  Mol Cell Proteomics       Date:  2018-01-22       Impact factor: 5.911

5.  Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective Endocarditis.

Authors:  Aubrey Watson; Jun Taek Oh; Karen Sauve; Patricia A Bradford; Cara Cassino; Raymond Schuch
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

6.  A Rarely Reported Case of Enterococcus faecalis Bacteremia Causing Infective Endocarditis and Osteomyelitis.

Authors:  Pradeep Kumar Devarakonda; Vishal R Dhulipala; Monika Karki; Cesar Ayala-Rodriguez; Sarath Reddy
Journal:  Cureus       Date:  2022-02-23

7.  Abdominal fascia dehiscence: is there a connection to a special microbial spectrum?

Authors:  P V Stropnicky; F Kandemir; M Schäffer; J Pochhammer
Journal:  Hernia       Date:  2022-09-22       Impact factor: 2.920

8.  Heme cross-feeding can augment Staphylococcus aureus and Enterococcus faecalis dual species biofilms.

Authors:  Jun-Hong Ch'ng; Mugil Muthu; Kelvin K L Chong; Jun Jie Wong; Casandra A Z Tan; Zachary J S Koh; Daniel Lopez; Artur Matysik; Zeus J Nair; Timothy Barkham; Yulan Wang; Kimberly A Kline
Journal:  ISME J       Date:  2022-05-19       Impact factor: 11.217

9.  Rare case of simultaneous enterococcal endocarditis and prosthetic joint infection.

Authors:  Sean I Tracy; Sherry-Ann Brown; John T Ratelle; Anjali Bhagra
Journal:  BMJ Case Rep       Date:  2016-05-20

10.  Enterococcal bacteraemia: predictive and prognostic risk factors for ampicillin resistance.

Authors:  T Matsumura; M Nagao; S Nakano; M Yamamoto; Y Matsumura; S Ichiyama
Journal:  Epidemiol Infect       Date:  2018-08-31       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.